Опубликовано в "Бизнес", язык - English. 5 страниц.
Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopharmacy growth. Еще
